• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
JIN Xutong,JIANG Zixian,WANG Xinyi,TIAN Jilai.Research progress on the biological basis of HDL transport to liver and its application as drug carrier[J].Journal Of Pharmaceutical Research,2024,43(4):373-379[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2458times   Download 2905次 QR Code for this article
Scan with your phone!
HDL向肝转运的生物学基础及作为药物载体应用的研究进展
金许曈1,江子贤1,王馨怡2,田吉来2
Font:Larger+|Default|Smaller-
(1.南京中医药大学泰州校区,江苏 泰州 225300;2.南京中医药大学医学院·整合医学学院,江苏 南京 210023)
摘要:
仿生纳米颗粒给药系统在高效给药方面具有巨大潜力。而高密度脂蛋白(high-density lipoprotein, HDL)作为天然纳米颗粒,具有高效运输性、高度安全性、特异靶向性和极强穿透性等特点,具有作为药物载体应用的潜能。仿生HDL的纳米药物传输系统研究越来越受到关注。本文将综述HDL的组成、结构、代谢等生物学基础及人工重构的HDL作为药物载体结构设计、制备方法及应用研究现状,以期为HDL药物载体材料的深入研究提供理论指导。
关键词:  高密度脂蛋白  逆向转运  清道夫受体  药物递送系统  纳米药物
DOI:10.13506/j.cnki.jpr.2024.04.011
基金项目:南京中医药大学大学生创新创业训练计划项目(No.103152022028)
Publication Date:April 25, 2024
Research progress on the biological basis of HDL transport to liver and its application as drug carrier
JIN Xutong1,JIANG Zixian1,WANG Xinyi2,TIAN Jilai2
(1.Nanjing University of Chinese Medicine Taizhou Campus, Taizhou 225300, China;2.School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China)
Abstract:
The development of biomimetic nanoparticle drug delivery systems is an emerging field with enormous potential for efficient drug delivery.High density lipoprotein (HDL), as a natural nanocarrier, possesses features such as high transport efficiency, high safety, specific targeting, and strong penetration, making it a potential drug carrier.The research on HDL-based nanoparticle drug delivery systems is increasingly gaining attention. This article will review the biological basis of HDL, including its composition, structure, metabolism, and its current status of research and application as a drug carrier of reconstituted HDL. The aim of this article is to provide new ideas for the in-depth study of HDL as drug carrier materials.
Key words:  High-density lipoprotein  Reverse transport  Scavenger receptor  Drug delivery system  Nanomedicine
Today's Visits:511    Total Visits:2383242
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.